Safety, Tolerability and Pharmacokinetics Study of AIR DNAse Administered by Inhalation to Healthy Adult Volunteers
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
This study will be performed to assess the safety, tolerability and PK of escalating inhaled
AIR-DNase doses administered as a single dose followed by multiple doses for 5 consecutive
days in healthy subjects.
A thorough review of safety data will be conducted after completion of each dose level per
subject and prior to both, moving to the next dose level in Part 1 and commencement of the
multiple dose Part 2.